In Brief: FDA's Curtis Wright, MD
This article was originally published in The Tan Sheet
Executive Summary
FDA's Curtis Wright, MD: Leaves FDA to join the recently formed company Adolor Pharmaceuticals as VP-research and regulatory affairs. Wright had been deputy director of FDA's Anesthetic, Critical Care & Addiction Drug Products Division. Adolor, based in Malvern, Penn., focuses on developing analgesic drug products...